2型糖尿病与胰腺癌术后并发症及预后研究进展
Research Progress on Postoperative Complications and Prognosis of Type 2 Diabetes and Pancreatic Cancer
DOI: 10.12677/ACM.2024.142578, PDF,    科研立项经费支持
作者: 章惊雷, 陈启龙*:新疆医科大学第一附属医院胰腺外科,新疆 乌鲁木齐;庄 言:新疆医科大学第一附属医院疼痛科,新疆 乌鲁木齐
关键词: 胰腺癌2型糖尿病并发症预后Pancreatic Cancer Type 2 Diabetes Complication Prognosis
摘要: 目的:2型糖尿病(T2DM)与胰腺癌(PC)之间的关系很复杂,目前国内外已对该研究相关方面进行详细讨论,但结果仍有争议,为进一步探讨T2DM与PC预后的关系,结合目前国内外的近期研究,总结其中的发生机制及相关研究进展。方法:检索近年国内外有关2型糖尿病与胰腺癌相关研究并进行综述。结果:T2DM与PC术后并发症的研究相对较少,是否影响胰瘘和胃排空延迟等并发症国内外研究存在较大争议,但是可以明确T2DM是PC预后的不利因素,并且高血糖状态不利于PC的预后,控制血糖是延长预后的重要环节。结论:T2DM对PC术后并发症的发生仍有争议,在胰腺外科临床治疗方面有借鉴价值和指导意义,明确T2DM与PC术后并发症的关系尚需制定更加详细的研究分组,进一步增加数据量研究。
Abstract: Objective: The relationship between type 2 diabetes mellitus (T2DM) and pancreatic cancer (PC) is very complicated. At present, the relevant aspects of this study have been discussed in detail at home and abroad, but the results are still controversial. In order to further explore the relationship between T2DM and PC prognosis, combined with recent studies at home and abroad, the pathogenesis and related research progress are summarized. Method: The research on type 2 dia-betes mellitus and pancreatic cancer at home and abroad in recent years was reviewed. Results: There are relatively few studies on postoperative complications of T2DM and PC, and there are great controversies in domestic and foreign studies on whether it affects complications such as pancreatic fistula and delayed gastric empting. However, it is clear that T2DM is an unfavorable factor for the prognosis of PC, and hyperglycemia is not conducive to the prognosis of PC, and blood glucose control is an important link to prolong the prognosis. Conclusion: T2DM is still controversial in the occurrence of postoperative complications of PC, and it has reference value and guiding significance in the clinical treatment of pancreatic surgery. To clarify the relationship between T2DM and postoperative complications of PC, more detailed research groups need to be developed to further increase the amount of data.
文章引用:章惊雷, 庄言, 陈启龙. 2型糖尿病与胰腺癌术后并发症及预后研究进展[J]. 临床医学进展, 2024, 14(2): 4177-4184. https://doi.org/10.12677/ACM.2024.142578

参考文献

[1] GBD 2017 Pancreatic Cancer Collaborators (2019) The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology and Hepatology, 4, 934-947.
[2] Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33 [Google Scholar] [CrossRef] [PubMed]
[3] 中华医学会外科学分会胰腺外科学组, 赵玉沛, 杨尹默, 等. 中国胰腺癌诊治指南(2021) [J]. 中华外科杂志, 2021, 59(7): 561-577.
[4] Sung, H., Siegel, R.L., Rosenberg, P.S., et al. (2019) Emerging Cancer Trends among Young Adults in the USA: Analysis of A Population-Based Cancer Registry. The Lancet Public Health, 4, E137-E147. [Google Scholar] [CrossRef
[5] Gallo, M., Adinolfi, V., Morviducci, L., et al. (2021) Early Prediction of Pancreatic Cancer from New-Onset Diabetes: An Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi(AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) Multidisciplinary Consensus Position Paper. ESMO Open, 6, Article ID: 100155. [Google Scholar] [CrossRef] [PubMed]
[6] Molina-Montes, E., et al. (2020) Deciphering the Complex Interplay between Pancreatic Cancer, Diabetes Mellitus Subtypes and Obesity/BMI through Causal Inference and Me-diation Analyses. Gut, 70, 319-329. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, L., Peng, W., Zhao, Z., et al. (2021) Prevalence and Treatment of Diabetes in China, 2013-2018. JAMA, 326, 2498-2506. [Google Scholar] [CrossRef] [PubMed]
[8] Shen, B.Y. (2023) Association between Age at Diabetes Onset or Diabetes Duration and Subsequent Risk of Pancreatic Cancer: Results from a Longitudinal Cohort and Mendelian Randomization Study. The Lancet Regional Health— Western Pacific, 30, Article ID: 100596. [Google Scholar] [CrossRef] [PubMed]
[9] Pang, Y.J., Kartsonaki, C., Guo, Y., et al. (2017) Diabetes, Plasma Glucose and Incidence of Pancreatic Cancer: A Prospective Study of 0.5 Million Chinese Adults and a Me-ta-Analysis of 22 Cohort Studies. International Journal of Cancer, 140, 1781-1788. [Google Scholar] [CrossRef] [PubMed]
[10] Klein, A.P. (2021) Pancreatic Cancer Epidemiology: Understanding the Role of Lifestyle and Inherited Risk Factors. Nature Reviews Gastroenterology & Hepatology, 18, 493-502. [Google Scholar] [CrossRef] [PubMed]
[11] Lam, B.Q., Shrivastava, S.K., Shrivastava, A., et al. (2020) The Impact of Obesity and Diabetes Mellitus on Pancreatic Cancer: Molecular Mechanisms and Clinical Perspectives. Journal of Cellular and Molecular Medicine, 24, 7706-7716. [Google Scholar] [CrossRef] [PubMed]
[12] 曾正洪, 陈智, 付前广, 等. 老年2型糖尿病合并胰腺癌的危险因素分析[J]. 临床消化病杂志, 2023, 35(3): 177-180.
[13] 段晓晔, 郭立新. 2型糖尿病与胰腺癌关系的研究进展[J]. 国际内分泌代谢杂志, 2022, 42(6): 473-476.
[14] Mizrahi, J.D., Surana, R., Valle, J.W. and Shroff, R.T. (2020) Pan-creatic Cancer. The Lancet, 395, 2008-2020. [Google Scholar] [CrossRef
[15] 2型糖尿病发病越早,胰腺癌风险越高[J]. 实用肿瘤学杂志, 2023, 37(2): 189.
[16] Liu, Y.H., Hu, C.M., Hsu, Y.S. and Lee, W.H. (2022) Interplays of Glucose Metabolism and KRAS Mutation in Pancreatic Ductal Adenocarcinoma. Cell Death & Disease, 13, Article No. 817. [Google Scholar] [CrossRef] [PubMed]
[17] Mungroop, T.H., Van Rijssen, L.B., Van Klaveren, D., et al. (2019) Alternative Fistula Risk Score for Pancreatoduodenectomy (A-FRS): Design and International External Validation. Annals of Surgery, 269, 937-943. [Google Scholar] [CrossRef
[18] Krautz, C., Haase, E., Elshafei, M., et al. (2019) The Impact of Surgical Experience and Frequency of Practice on Perioperative Outcomes in Pancreatic Surgery. BMC Surgery, 19, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[19] Schuh, F., Mihaljevic, A.L., Probst, P., et al. (2023) A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A Classification of the International Study Group of Pancreatic Surgery. Annals of Surgery, 277, e597-e608. [Google Scholar] [CrossRef
[20] Ratnayake, C.B.B., Wells, C.I., Kamarajah, S.K., et al. (2020) Critical Appraisal of the Techniques of Pancreatic Anastomosis following Pancreaticoduodenectomy: A Network Meta-Analysis. International Journal of Surgery, 73, 72-77. [Google Scholar] [CrossRef] [PubMed]
[21] Atkinson, M.A., Campbell-Thompson, M., Kusmartseva, I., et al. (2020) Organisation of the Human Pancreas in Health and in Diabetes. Diabetologia, 63, 1966-1973. [Google Scholar] [CrossRef] [PubMed]
[22] Hu, F., Qiu, X. and Bu, S. (2020) Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Archives of Physiology and Biochemistry, 126, 235-241. [Google Scholar] [CrossRef] [PubMed]
[23] Malleo, G., Mazzarella, F., Malpaga, A., et al. (2013) Dia-betes Mellitus Does Not Impact on Clinically Relevant Pancreatic Fistula after Partial Pancreatic Resection for Ductal Adenocarcinoma. Surgery, 153, 641-650. [Google Scholar] [CrossRef] [PubMed]
[24] 端传友, 王新波. 2型糖尿病对胰腺癌患者胰十二指肠切除术后早期并发症的影响[J]. 中国综合临床, 2016, 32(2): 160-164.
[25] Unnikrishnan, R. and Misra, A. (2020) Infections and Diabetes: Risks and Mitigation with Reference to India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 1889-1894. [Google Scholar] [CrossRef] [PubMed]
[26] Mor, A., Dekkers, O.M., Nielsen, J.S., et al. (2017) Impact of Glycemic Control on Risk of Infections in Patients with Type 2 Diabetes: A Population-Based Cohort Study. American Journal of Epidemiology, 186, 227-236. [Google Scholar] [CrossRef] [PubMed]
[27] Critchley, J., Carey, I.M., Harris, T., et al. (2018) Glycemic Control and Risk of Infections among People with Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care, 41, 2127-2135. [Google Scholar] [CrossRef] [PubMed]
[28] Mor, A., Dekkers, O.M., Nielsen, J.S., et al. (2017) Impact of Glycemic Control on Risk of Infections in Patients with Type 2 Diabetes: A Population-Based Cohort Study. American Journal of Epidemiology, 186, 227-236. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, Y.Y., Hu, S.F., Ying, H.M., et al. (2018) Postoperative Tight Glycemic Control Significantly Reduces Postoperative Infection Rates in Patients Undergoing Surgery: A Meta-Analysis. BMC Endocrine Disorders, 18, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[30] Zhou, S.Y., Lu, Y., Song, I. and Owyang, C. (2011) Inhibition of Gastric Motility by Hyperglycemia Is Mediated by Nodose Ganglia KATP Channels. American Journal of Physiology-Gastrointestinal and Liver Physiology, 300, G394-G400. [Google Scholar] [CrossRef] [PubMed]
[31] Raghavan, S.R., Ballehaninna, U.K. and Chamberlain, R.S. (2013) The Impact of Perioperative Blood Glucose Levels on Pancreatic Cancer Prognosis and Surgical Outcomes: An Evi-dence-Based Review. Pancreas, 42, 1210-1217. [Google Scholar] [CrossRef
[32] Eshuis, W.J., Hermanides, J., Van Dalen, J.W., et al. (2011) Early Postoperative Hyperglycemia Is Associated with Postoperative Complications after Pancreatoduodenectomy. Annals of Surgery, 253, 739-744. [Google Scholar] [CrossRef
[33] 安革利, 董峰, 宋利芳. 胰腺癌根治术后患者预后的相关影响因素[J]. 实用癌症杂志, 2023, 38(1): 126-128, 132.
[34] Birch, R.J., Downing, A., Finan, P.J., et al. (2021) Improving Outcome Prediction in Individuals with Colorectal Cancer and Diabetes by Accurate Assessment of Vascular Complications: Implications for Clinical Practice. European Journal of Surgical Oncology, 47, 999-1004 [Google Scholar] [CrossRef] [PubMed]
[35] 孙龙, 昊张, 杨陈岩. 肥胖和2型糖尿病对胰腺癌促进作用的研究进展[J]. 中华普通外科杂志, 2023, 38(1): 66-70.
[36] 周聪雅, 金龙, 张苏, 等. 糖脂代谢与胰腺癌患者预后相关性分析[J]. 陕西医学杂志, 2023, 52(9): 1218-1220, 1224.
[37] Khadka, R., Tian, W., Hao, X. and Koira, R. (2018) Risk Factor, Early Diagnosis and Overall Survival on Outcome of Association between Pancreatic Cancer and Diabetes Mellitus: Changes and Advances, a Review. International Journal of Surgery, 52, 342-346. [Google Scholar] [CrossRef] [PubMed]
[38] Toriola, A.T., Stolzenberg-Solomon, R., Dalidowitz, L., Linehan, D. and Colditz, G. (2014) Diabetes and Pancreatic Cancer Survival: A Prospective Cohort-Based Study. British Journal of Cancer, 111, 181-185. [Google Scholar] [CrossRef] [PubMed]
[39] Yuan, C., Rubinson, D.A., Qian, Z.R., et al. (2015) Survival among Pa-tients with Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus. Journal of Clinical Oncology, 33, 29-35. [Google Scholar] [CrossRef
[40] Hsieh, M.C., Zhang, L., Velasco-Gonzalez, C., et al. (2022) Impact of Diabetes and Modifiable Risk Factors on Pancreatic Cancer Survival in a Population-Based Study after Adjusting for Clinical Factors. Cancer Causes & Control, 33, 37-48. [Google Scholar] [CrossRef] [PubMed]